SlideShare a Scribd company logo
When a Premarket Approval (PMA) 
is Required 
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
Instructor Profile: 
Ronald Schoengold is a consultant to the biotechnology, pharmaceutical and 
medical device industry. He is a certified regulatory affairs professional and Fellow 
of the Regulatory Affairs Professional Society. Ron provides advice on quality, 
regulatory and product development issues, helping businesses effectively 
commercialize and maintain their products and services. He has been an active 
contributor to the industry for over 45 years and has developed commercially 
successful pharmaceutical, screening and diagnostic products for GI medicine, 
infectious disease and point-of-care testing. Ron is also an advisor to the Larta 
Institute, an NIH supported group that assists young companies who receive SBIR 
grants. He has published scientific journal articles and presented seminars and 
webinars on scientific and current regulatory compliance topics. Ron also co-authored 
a book chapter on point-of-care testing and holds 8 patents related to 
point-of-care diagnostics. He earned his bachelor’s degree in biology and 
chemistry, did his master’s training in microbiology and biochemistry, and 
completed additional graduate studies in microbiology, genetics, molecular biology 
and immunology. 
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
Description: 
The decision to submit a PMA should be taken only after a comprehensive 
review of existing technologies and similar marketed medical devices, previously 
classified by the FDA. The starting point in deciding if a PMA is appropriate is a 
comprehensive risk assessment of the device based on the intended uses and 
indications for use. The PMA application and review is a multistep interactive 
process that imposes substantial administrative requirements, protracted time 
elements, and financial burdens on the submitter. 
FDA utilizes the premarket approval (PMA) process to determine if Class III 
devices are safe and effective based on objective scientific evidences. FDA defines 
Class III devices as those that support or sustain human life, are of substantial 
importance in preventing impairment of human health, or which have the 
potential of unreasonable risk of illness or injury to an individual. 
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
Why Should you Attend: 
Attend this webinar to learn about when you require a premarket approval for a 
medical device. A PMA approval from FDA grants the submitter a private license to legally 
market the device. The decision to submit a PMA should be taken only after an in depth 
assessment of the potential business risks and rewards. 
Objectives of the Presentation: 
The objectives of the presentation are to discuss about: 
• Historical PMA overview 
• Classification of new or novel technologies and medical devices 
• De novo route 
• PMA timeline 
• Pre-submission meetings with FDA 
• Non-clinical studies 
• Clinical investigations 
• Foreign studies 
• User fees 
• Quality System requirements 
• Value assessment 
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
Who can Benefit: 
Regulatory & Quality Assurance Managers, Product Managers, Program Managers, 
Research and Development 
Live Session - How it 
works 
• Username and Password will be sent 
to you 24 hours prior to the webinar 
• Presentation handouts in pdf formate 
will be mailed to you 
• Login to the session using the 
username and password provided to 
you 
• Get answer to your queries through 
interactive Q&A sessions via chat 
• Please let us know your thoughts and 
views at the end of webinar, your 
valuable feedback will help us 
improve 
• Get certification of attendance. 
Recorded Session - How it 
works 
• A link will be provided to you upon 
purchase of the recorded session 
• Please click on the link to access the 
session 
• Presentation handouts in pdf formate 
will be mailed to you 
• Get certification of attendance. 
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
Reach us on : 
www.onlinecompliancepanel.com 
Our 
links 
www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com

More Related Content

What's hot

Current regulatory expectation
Current regulatory expectationCurrent regulatory expectation
Current regulatory expectation
OnlineCompliance Panel
 
Why Patients Require Improved Referral Management From Their Doctors?
Why Patients Require Improved Referral Management From Their Doctors?Why Patients Require Improved Referral Management From Their Doctors?
Why Patients Require Improved Referral Management From Their Doctors?
GaryRichards30
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreviewDaria Binder
 
Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...
Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...
Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...
Greenlight Guru
 
Fda at-my-facility-cape-town
Fda at-my-facility-cape-townFda at-my-facility-cape-town
Fda at-my-facility-cape-town
GlobalCompliancePanel
 
Effective root cause analysis
Effective root cause analysisEffective root cause analysis
Effective root cause analysis
OnlineCompliance Panel
 
why FDA at my Facility is, and what do I do During an Inspection
why FDA at my Facility is, and what do I do During an Inspectionwhy FDA at my Facility is, and what do I do During an Inspection
why FDA at my Facility is, and what do I do During an Inspection
GlobalCompliancePanel
 
Patient access ROI's
Patient access ROI'sPatient access ROI's
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
Obaid Ali / Roohi B. Obaid
 
Patient Centric Technology - Leverage integrated technology to engage patient...
Patient Centric Technology - Leverage integrated technology to engage patient...Patient Centric Technology - Leverage integrated technology to engage patient...
Patient Centric Technology - Leverage integrated technology to engage patient...
John Reites
 
Digital Health & Wellness Summit @ Mobile World Congress 2016
Digital Health & Wellness Summit @ Mobile World Congress 2016Digital Health & Wellness Summit @ Mobile World Congress 2016
Digital Health & Wellness Summit @ Mobile World Congress 2016
3GDR
 
Australian pre exercise screen - the new standard
Australian pre exercise screen - the new standardAustralian pre exercise screen - the new standard
Australian pre exercise screen - the new standard
Fitness Australia
 
Pre exercise cv screening tool launch
Pre exercise cv screening tool launchPre exercise cv screening tool launch
Pre exercise cv screening tool launchMax Martin
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
I3CGLOBAL
 
RS Presentation
RS PresentationRS Presentation
RS PresentationRS Serve
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with Project
BioMed Informatics
 
Synergy CRO capabilities as of 4 Aug 2016
Synergy CRO capabilities as of 4 Aug 2016Synergy CRO capabilities as of 4 Aug 2016
Synergy CRO capabilities as of 4 Aug 2016
Igor Stefanov
 

What's hot (20)

Current regulatory expectation
Current regulatory expectationCurrent regulatory expectation
Current regulatory expectation
 
Why Patients Require Improved Referral Management From Their Doctors?
Why Patients Require Improved Referral Management From Their Doctors?Why Patients Require Improved Referral Management From Their Doctors?
Why Patients Require Improved Referral Management From Their Doctors?
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreview
 
Laboratory Medicine Best Practices (LMBP)
Laboratory Medicine Best Practices (LMBP)Laboratory Medicine Best Practices (LMBP)
Laboratory Medicine Best Practices (LMBP)
 
Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...
Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...
Bridging User Needs & Design Requirements: Answers are Only as Good as the Qu...
 
Fda at-my-facility-cape-town
Fda at-my-facility-cape-townFda at-my-facility-cape-town
Fda at-my-facility-cape-town
 
Effective root cause analysis
Effective root cause analysisEffective root cause analysis
Effective root cause analysis
 
why FDA at my Facility is, and what do I do During an Inspection
why FDA at my Facility is, and what do I do During an Inspectionwhy FDA at my Facility is, and what do I do During an Inspection
why FDA at my Facility is, and what do I do During an Inspection
 
Patient access ROI's
Patient access ROI'sPatient access ROI's
Patient access ROI's
 
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
 
Patient Centric Technology - Leverage integrated technology to engage patient...
Patient Centric Technology - Leverage integrated technology to engage patient...Patient Centric Technology - Leverage integrated technology to engage patient...
Patient Centric Technology - Leverage integrated technology to engage patient...
 
Digital Health & Wellness Summit @ Mobile World Congress 2016
Digital Health & Wellness Summit @ Mobile World Congress 2016Digital Health & Wellness Summit @ Mobile World Congress 2016
Digital Health & Wellness Summit @ Mobile World Congress 2016
 
Australian pre exercise screen - the new standard
Australian pre exercise screen - the new standardAustralian pre exercise screen - the new standard
Australian pre exercise screen - the new standard
 
Pre exercise cv screening tool launch
Pre exercise cv screening tool launchPre exercise cv screening tool launch
Pre exercise cv screening tool launch
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
 
RS Presentation
RS PresentationRS Presentation
RS Presentation
 
Immunization Cetrificate
Immunization CetrificateImmunization Cetrificate
Immunization Cetrificate
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with Project
 
Synergy CRO capabilities as of 4 Aug 2016
Synergy CRO capabilities as of 4 Aug 2016Synergy CRO capabilities as of 4 Aug 2016
Synergy CRO capabilities as of 4 Aug 2016
 
Recasting patient access
Recasting patient accessRecasting patient access
Recasting patient access
 

Viewers also liked

Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
marchell
 
3 pma salehuddin - analysis osh legislation
3   pma salehuddin - analysis osh legislation3   pma salehuddin - analysis osh legislation
3 pma salehuddin - analysis osh legislation
Capt(Rtd) Salehuddin Abdul Kadir
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to Market
MethodSense, Inc.
 
FDA Inspection
FDA InspectionFDA Inspection
Preparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee ReviewPreparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee Review
guest22cdb3
 
Combination Products
Combination ProductsCombination Products
Combination Products
chemist874
 
Handling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sHandling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sArun Purohit
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1
Jorge Torres
 
Getting Your Medical Device FDA Approved
Getting Your Medical Device FDA ApprovedGetting Your Medical Device FDA Approved
Getting Your Medical Device FDA Approved
mentoresd
 
MEDICAL DEVICE DEVELOPMENT_0327
MEDICAL DEVICE DEVELOPMENT_0327MEDICAL DEVICE DEVELOPMENT_0327
MEDICAL DEVICE DEVELOPMENT_0327Robert Stathopulos
 
US FDA medical device approval chart - Emergo
US FDA medical device approval chart - Emergo US FDA medical device approval chart - Emergo
US FDA medical device approval chart - Emergo
EMERGO
 
Medical device development lifecycle
Medical device development lifecycleMedical device development lifecycle
Medical device development lifecycle
Tim Blair
 
FDA Audit - The Do and Don't List
FDA Audit - The Do and Don't ListFDA Audit - The Do and Don't List
FDA Audit - The Do and Don't List
Compliance Insight, Inc.
 

Viewers also liked (13)

Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 
3 pma salehuddin - analysis osh legislation
3   pma salehuddin - analysis osh legislation3   pma salehuddin - analysis osh legislation
3 pma salehuddin - analysis osh legislation
 
FDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to MarketFDA Regulations and Medical Device Pathways to Market
FDA Regulations and Medical Device Pathways to Market
 
FDA Inspection
FDA InspectionFDA Inspection
FDA Inspection
 
Preparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee ReviewPreparing For An FDA Inspection - Employee Review
Preparing For An FDA Inspection - Employee Review
 
Combination Products
Combination ProductsCombination Products
Combination Products
 
Handling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont'sHandling FDA Inspection - Do's and Dont's
Handling FDA Inspection - Do's and Dont's
 
FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1FDA PreApproval Inspection - Part 1
FDA PreApproval Inspection - Part 1
 
Getting Your Medical Device FDA Approved
Getting Your Medical Device FDA ApprovedGetting Your Medical Device FDA Approved
Getting Your Medical Device FDA Approved
 
MEDICAL DEVICE DEVELOPMENT_0327
MEDICAL DEVICE DEVELOPMENT_0327MEDICAL DEVICE DEVELOPMENT_0327
MEDICAL DEVICE DEVELOPMENT_0327
 
US FDA medical device approval chart - Emergo
US FDA medical device approval chart - Emergo US FDA medical device approval chart - Emergo
US FDA medical device approval chart - Emergo
 
Medical device development lifecycle
Medical device development lifecycleMedical device development lifecycle
Medical device development lifecycle
 
FDA Audit - The Do and Don't List
FDA Audit - The Do and Don't ListFDA Audit - The Do and Don't List
FDA Audit - The Do and Don't List
 

Similar to When a premarket approval (pma) is req

Best practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'tsBest practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'ts
OnlineCompliance Panel
 
Documenting software for fda submissions
Documenting software for fda submissionsDocumenting software for fda submissions
Documenting software for fda submissions
GlobalCompliancePanel
 
documenting software for fda submissions
documenting software for fda submissionsdocumenting software for fda submissions
documenting software for fda submissions
GlobalCompliancePanel
 
How fda trains its investigators to review capa
How fda trains its investigators to review capaHow fda trains its investigators to review capa
How fda trains its investigators to review capa
OnlineCompliance Panel
 
Agenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA ConferenceAgenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA ConferenceRachel Starnes
 
Preparing for fda
Preparing for fdaPreparing for fda
Preparing for fdasupportc2go
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairs
Rafat Abedi (IGMPI)
 
Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.
OnlineCompliance Panel
 
Difficulties in Meeting GMP-GMP Compliance
Difficulties in Meeting GMP-GMP ComplianceDifficulties in Meeting GMP-GMP Compliance
Difficulties in Meeting GMP-GMP Compliance
OnlineCompliance Panel
 
4 training courses on fda rules and regulations
4 training courses on fda rules and regulations4 training courses on fda rules and regulations
4 training courses on fda rules and regulations
OnlineCompliance Panel
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
Namdeo Shinde
 
Production and Process Control: Building a Robust System for Medical Device C...
Production and Process Control: Building a Robust System for Medical Device C...Production and Process Control: Building a Robust System for Medical Device C...
Production and Process Control: Building a Robust System for Medical Device C...
OnlineCompliance Panel
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
Wildfrontech
 
Navigant Resume Gina LaBella-Tulin MS 2016
Navigant Resume Gina LaBella-Tulin MS 2016Navigant Resume Gina LaBella-Tulin MS 2016
Navigant Resume Gina LaBella-Tulin MS 2016Gina Labella-Tulin
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
Fda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trialsFda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trials
GlobalCompliancePanel
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
Sigma
 

Similar to When a premarket approval (pma) is req (20)

Best practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'tsBest practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'ts
 
Documenting software for fda submissions
Documenting software for fda submissionsDocumenting software for fda submissions
Documenting software for fda submissions
 
documenting software for fda submissions
documenting software for fda submissionsdocumenting software for fda submissions
documenting software for fda submissions
 
How fda trains its investigators to review capa
How fda trains its investigators to review capaHow fda trains its investigators to review capa
How fda trains its investigators to review capa
 
Agenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA ConferenceAgenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA Conference
 
Preparing for fda
Preparing for fdaPreparing for fda
Preparing for fda
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairs
 
Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.
 
Difficulties in Meeting GMP-GMP Compliance
Difficulties in Meeting GMP-GMP ComplianceDifficulties in Meeting GMP-GMP Compliance
Difficulties in Meeting GMP-GMP Compliance
 
4 training courses on fda rules and regulations
4 training courses on fda rules and regulations4 training courses on fda rules and regulations
4 training courses on fda rules and regulations
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Production and Process Control: Building a Robust System for Medical Device C...
Production and Process Control: Building a Robust System for Medical Device C...Production and Process Control: Building a Robust System for Medical Device C...
Production and Process Control: Building a Robust System for Medical Device C...
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
Navigant Resume Gina LaBella-Tulin MS 2016
Navigant Resume Gina LaBella-Tulin MS 2016Navigant Resume Gina LaBella-Tulin MS 2016
Navigant Resume Gina LaBella-Tulin MS 2016
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
Fda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trialsFda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trials
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
 

Recently uploaded

Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 

Recently uploaded (20)

Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 

When a premarket approval (pma) is req

  • 1. When a Premarket Approval (PMA) is Required www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
  • 2. Instructor Profile: Ronald Schoengold is a consultant to the biotechnology, pharmaceutical and medical device industry. He is a certified regulatory affairs professional and Fellow of the Regulatory Affairs Professional Society. Ron provides advice on quality, regulatory and product development issues, helping businesses effectively commercialize and maintain their products and services. He has been an active contributor to the industry for over 45 years and has developed commercially successful pharmaceutical, screening and diagnostic products for GI medicine, infectious disease and point-of-care testing. Ron is also an advisor to the Larta Institute, an NIH supported group that assists young companies who receive SBIR grants. He has published scientific journal articles and presented seminars and webinars on scientific and current regulatory compliance topics. Ron also co-authored a book chapter on point-of-care testing and holds 8 patents related to point-of-care diagnostics. He earned his bachelor’s degree in biology and chemistry, did his master’s training in microbiology and biochemistry, and completed additional graduate studies in microbiology, genetics, molecular biology and immunology. www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
  • 3. Description: The decision to submit a PMA should be taken only after a comprehensive review of existing technologies and similar marketed medical devices, previously classified by the FDA. The starting point in deciding if a PMA is appropriate is a comprehensive risk assessment of the device based on the intended uses and indications for use. The PMA application and review is a multistep interactive process that imposes substantial administrative requirements, protracted time elements, and financial burdens on the submitter. FDA utilizes the premarket approval (PMA) process to determine if Class III devices are safe and effective based on objective scientific evidences. FDA defines Class III devices as those that support or sustain human life, are of substantial importance in preventing impairment of human health, or which have the potential of unreasonable risk of illness or injury to an individual. www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
  • 4. Why Should you Attend: Attend this webinar to learn about when you require a premarket approval for a medical device. A PMA approval from FDA grants the submitter a private license to legally market the device. The decision to submit a PMA should be taken only after an in depth assessment of the potential business risks and rewards. Objectives of the Presentation: The objectives of the presentation are to discuss about: • Historical PMA overview • Classification of new or novel technologies and medical devices • De novo route • PMA timeline • Pre-submission meetings with FDA • Non-clinical studies • Clinical investigations • Foreign studies • User fees • Quality System requirements • Value assessment www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
  • 5. Who can Benefit: Regulatory & Quality Assurance Managers, Product Managers, Program Managers, Research and Development Live Session - How it works • Username and Password will be sent to you 24 hours prior to the webinar • Presentation handouts in pdf formate will be mailed to you • Login to the session using the username and password provided to you • Get answer to your queries through interactive Q&A sessions via chat • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve • Get certification of attendance. Recorded Session - How it works • A link will be provided to you upon purchase of the recorded session • Please click on the link to access the session • Presentation handouts in pdf formate will be mailed to you • Get certification of attendance. www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com
  • 6. Reach us on : www.onlinecompliancepanel.com Our links www.onlinecompliancepanel.com | 510-857-5896 | customersupport@onlinecompliancepanel.com